appears in the following:

CDC Warns Against Off-Label Use Of COVID Vaccine

Thursday, September 02, 2021

Using the COVID vaccine "off-label" — whether that's for booster shots or young children — may be tempting to some vaccine providers, but the CDC warns it could get them into trouble.

Comment

The U.S. Paid Billions To Get Enough COVID Vaccines Last Fall. What Went Wrong?

Wednesday, August 25, 2021

Immediately after the Food and Drug Administration authorized Pfizer's vaccine, the company delivered fewer doses than its government contract projected. Federal officials say they didn't know why.

Comment

COVID Booster Shots Are Coming. Here's What You Need To Know

Thursday, August 19, 2021

If all goes to plan, Americans who got Pfizer or Moderna shots can get a third dose eight months after their last jab. Here's why health officials think you'll need one.

Comment

Lawmakers Grill Vaccine Factory Executives About Manufacturing Mistakes

Wednesday, May 19, 2021

House subcommittee members questioned why Emergent BioSoultions awarded bonuses to executives despite quality problems than hindered production of Johnson & Johnson's COVID-19 vaccine.

Comment

U.S. Backs Waiving International Patent Protections For COVID Vaccines

Thursday, May 06, 2021

President Biden threw his support behind a World Trade Organization proposal that would waive intellectual property protections for COVID-19 vaccines — allowing countries to make their own vaccines.

Comment

Why There Will Be Fewer Johnson & Johnson COVID-19 Vaccines Next Week

Friday, April 09, 2021

A dip of 86% in doses to be distributed to states follows a surge that occurred after one of J&J's third party manufacturers was finally able to release a stockpile.

Comment

States Will Have 86% Fewer Johnson & Johnson Doses Next Week Than It Did This Week

Friday, April 09, 2021

Johnson & Johnson has struggled with serious supply problems. Next week, states will have 86% fewer of the doses to dole out than they did this week.

Comment

Johnson & Johnson Vaccine Batch Ruined At Baltimore Factory, Drug Giant Says

Thursday, April 01, 2021

The COVID-19 vaccine by Johnson and Johnson has hit a snag. One the facilities making a key ingredient didn't pass quality inspection — possibly impacting 15 million doses.

Comment

Operation Warp Speed's Slaoui Ousted From Medical Company Board Over Misconduct Claim

Wednesday, March 24, 2021

Moncef Slaoui, who helped lead Operation Warp Speed under the Trump administration, was removed from a medical device startup's board over allegations of sexual harassment.

Comment

Defense Production Act Speeds Up Vaccine Production

Saturday, March 13, 2021

A 1950 law allows the government to award contracts that take priority over all others for national defense. During the pandemic, the law has been used to defend the country against the coronavirus.

Comment

Moderna And Pfizer On Track To Hit Vaccine Production Goals

Thursday, March 11, 2021

Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.

Comment

Moderna And Pfizer Will Need To Double Production To Hit U.S. Vaccination Target

Thursday, March 11, 2021

To hit their U.S. target of 220 million shots by the end of March, Moderna and Pfizer will need to double the number of doses they're currently delivering each week.

Comment

Normally Competitors, Merck To Produce Vaccines For Johnson & Johnson

Tuesday, March 02, 2021

Pharmaceutical giant Merck has not had success with its own COVID-19 vaccine, but has entered a deal to produce vaccines for Johnson & Johnson, who could use the help after production shortfalls.

Comment

Merck Will Help Manufacture Johnson & Johnson's COVID-19 Vaccine

Tuesday, March 02, 2021

Merck traditionally has been a leader in vaccines but has not had success with a COVID-19 vaccine. It's lending a hand to Johnson & Johnson, where production is running significantly behind schedule.

Comment

FDA Aims To Be 'Nimble' On COVID-19 Vaccine Changes For Variants

Thursday, February 11, 2021

The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.

Comment

With Coronavirus Variants On The Rise, Vaccine Companies And FDA Pivot

Wednesday, February 10, 2021

Coronavirus variants are on the rise, which means changes to the COVID-19 vaccines will be needed. How will the companies do that efficiently, and what will the Food and Drug Administration require?

Comment

Moderna Increases COVID-19 Vaccine Shipments While Pfizer Lags Behind

Monday, February 01, 2021

The two companies producing COVID-19 vaccines for use in the United States will have to raise production to meet contractual goals of 100 million doses each by the end of March.

Comment

How COVID-19 Vaccine Production Affects Vaccination Drives

Monday, February 01, 2021

Moderna is rapidly increasing production of COVID-19 vaccine for the U.S., and Pfizer is lagging behind. NPR looks at the production trends to see what it means for vaccination drives.

Comment

Moderna And Pfizer Need To Nearly Double COVID-19 Vaccine Deliveries To Meet Goals

Friday, January 22, 2021

The two companies making COVID-19 vaccines each promised to deliver 100 million doses to the federal government by the end of March. So far, they appear to be running behind.

Comment

The Nation's Coronavirus Vaccine Rollout Plan Faces Another Obstacle

Friday, January 22, 2021

The COVID-19 vaccine rollout faces another bottleneck: Pfizer and Moderna may be unable to fulfill contractual promises to deliver 100 million doses a piece to the federal government by March 31.

Comment